Applying REWIND CVD criteria to SUSTAIN 6 and PIONEER 6: an exploratory analysis of CV outcomes with semaglutide

Citation
Verma S, Fainberg U, Husain M, et al. Poster 1209-086 presented at ACC.20/WCC Virtual, 28 March 2020.